Compass Therapeutics (CMPX) Stock Price & Financial Analysis
Compass Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Compass Therapeutics
What is the current stock price for CMPX?
As of the latest trading session, CMPX stock trades at $2.02. The 52-week range is $1.61–$6.88, with a day range of $2.02–$2.10.
What is the P/E ratio for CMPX?
The P/E ratio (Price-to-Earnings) for CMPX is shown in the Key Statistics section. This valuation metric helps compare Compass Therapeutics, Inc. to industry peers.
Does CMPX pay dividends?
Compass Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CMPX?
Based on 11 analysts, the consensus for CMPX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of CMPX?
Compass Therapeutics's market capitalization is $376.5M, classifying it as a small-cap company. Compass Therapeutics operates in the Healthcare sector within the Biotechnology industry.